Drug intelligence / Profile preview

hymecromone

Development stage
Phase 2
Lead developer
Halo Biosciences
Modality
Small Molecules
Administration
Oral
01

Overview

Hymecromone is a coumarin derivative used primarily as a choleretic and biliary antispasmodic agent. It acts by stimulating the production and secretion of bile while exerting a selective spasmolytic effect on the Sphincter of Oddi and the bile ducts, thereby facilitating bile flow into the duodenum and relieving biliary colic. Beyond its clinical use in treating biliary dyskinesia and cholelithiasis, hymecromone is widely utilized in biochemical research as 4-methylumbelliferone (4-MU), where it serves as a potent inhibitor of hyaluronan synthesis. It achieves this by depleting the cellular pool of UDP-glucuronic acid and downregulating hyaluronan synthase 2 (HAS2). This research application has led to investigations into its potential anti-tumor, anti-fibrotic, and anti-inflammatory properties in various preclinical models.

Brand names
CantabilinCholestilMendiaxonCrodimylImechromoneMedillaOmega
Other names
7-hydroxy-4-methylcoumarin4-methylumbelliferone羟甲香豆素
02

Targets

HAS1 (Hyaluronan synthase 2)

Beyond the preview

Go deeper on hymecromone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hymecromone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call